back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-12-18 09:00 Tx date 2023-11-07 |
$PHRX
Pharmadrug Inc. |
Kideckel, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
1,107,143 | |
| Filed 2023-10-24 11:24 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Kideckel, David
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-642,857 vol |
107,143 | |
| Filed 2023-04-10 18:19 Tx date 2023-04-04 |
$IGX
IntelGenx Technologies Corp. |
Kideckel, David
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
97 - Other
|
+50,000 vol |
50,000 | |
| Filed 2023-04-10 18:18 Tx date 2023-03-20 |
$IGX
IntelGenx Technologies Corp. |
Kideckel, David
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-04-10 18:17 Tx date 2023-04-04 |
$IGX
IntelGenx Technologies Corp. |
Kideckel, David
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
250,000 | |
| Filed 2023-04-10 14:28 Tx date 2023-03-20 |
$IGX
IntelGenx Technologies Corp. |
Kideckel, David
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-08-31 12:33 Tx date 2021-08-30 |
$PHRX
Pharmadrug Inc. |
Kideckel, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+750,000 vol |
750,000 | |
| Filed 2021-08-31 12:32 Tx date 2021-08-30 |
$PHRX
Pharmadrug Inc. |
Kideckel, David
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-08-31 12:32 Tx date 2021-08-30 |
$PHRX
Pharmadrug Inc. |
Kideckel, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|